We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
신규 편입 · 포트폴리오 비중 0.03%
신규 편입 · 포트폴리오 비중 0.02%
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $16.33 · 9 analysts
Stored first · Google News · Yahoo Finance (English)
Lobbying Update: $500,000 of ARDELYX INC. lobbying was just disclosed - Quiver Quantitative
Lobbying Update: $500,000 of ARDELYX INC. lobbying was just disclosed Quiver Quantitative
Trading the Move, Not the Narrative: (ARDX) Edition - Stock Traders Daily
Trading the Move, Not the Narrative: (ARDX) Edition Stock Traders Daily
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’ - Stocktwits
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’ Stocktwits
Wedbush Maintains Ardelyx(ARDX.US) With Buy Rating, Raises Target Price to $19 - Moomoo
Wedbush Maintains Ardelyx(ARDX.US) With Buy Rating, Raises Target Price to $19 Moomoo
ARDX Stock Jumps Over 5% Overnight As Director Loads Up In Vote Of Confidence For Flagship Constipation Drug - Stocktwits
ARDX Stock Jumps Over 5% Overnight As Director Loads Up In Vote Of Confidence For Flagship Constipation Drug Stocktwits
Ardelyx Secures New $50 Million Term F Loan - The Globe and Mail
Ardelyx Secures New $50 Million Term F Loan The Globe and Mail
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 04. 30. | After market close (AMC) | $-0.04 | — | — | $128.24M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.17 | — | — | $74.11M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.19 | — | — | $217.49M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.18 | — | — | $119.25M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 02. 23. | Wedbush | — | Maintain | Outperform → Outperform | — | Wedbush: Outperform |
| 2026. 02. 20. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 02. 20. | BTIG | — | Maintain | Buy → Buy | — | BTIG: Buy |
| 2026. 01. 29. | BTIG | — | Maintain | Buy → Buy | — | BTIG: Buy |
| 2026. 01. 21. | Wedbush | — | Maintain | Outperform → Outperform | — | Wedbush: Outperform |
| 2026. 01. 10. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 4,274,043 | $25.6M | 0.02% | — | New position |
| 2 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 2,984,261 | $17.88M | 0.03% | — | New position |
| 3 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 2,873,969 | $16.76M | 0.03% | — | New position |
| 4 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 958,690 | $5.59M | 0.01% | — | New position |